Focusing on PYCR1 as a prioritized IMRG candidate due to its high expression in ccRCC cell lines, we conducted preclinical ccRCC cells to unravel its pathobiological contributions. The gene discussed is PYCR1; the disease is nonpapillary renal cell carcinoma.